Two Sigma Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,967
| Closed | -$5.14M | – | 2605 |
|
|
2025
Q1 | $5.14M | Sell |
38,967
-104,300
| -73% | -$13.8M | 0.01% | 779 |
|
|
2024
Q4 | $12M | Buy |
+143,267
| New | +$12M | 0.03% | 435 |
|
|
2022
Q1 | – | Sell |
-11,467
| Closed | -$600K | – | 2949 |
|
|
2021
Q4 | $600K | Buy |
+11,467
| New | +$600K | ﹤0.01% | 1829 |
|
|
2020
Q2 | – | Sell |
-12,467
| Closed | -$192K | – | 2623 |
|
|
2020
Q1 | $192K | Sell |
12,467
-10,500
| -46% | -$162K | ﹤0.01% | 2182 |
|
|
2019
Q4 | $788K | Sell |
22,967
-115,800
| -83% | -$3.97M | ﹤0.01% | 1676 |
|
|
2019
Q3 | $1.04M | Sell |
138,767
-26,200
| -16% | -$196K | ﹤0.01% | 1420 |
|
|
2019
Q2 | $2.14M | Buy |
164,967
+39,100
| +31% | +$507K | 0.01% | 1181 |
|
|
2019
Q1 | $1.53M | Buy |
125,867
+97,600
| +345% | +$1.19M | ﹤0.01% | 1335 |
|
|
2018
Q4 | $322K | Buy |
+28,267
| New | +$322K | ﹤0.01% | 1956 |
|